Moving to standardize and improve its process of assessing clinical data of new in-vitro medical devices, China’s National Medical Products Administration (NMPA) in late November published new draft guidelines for IVD clinical trials. Firms either renewing or applying for new product registrations... Read More
Just two multinational pharmaceutical manufacturers have been selected to supply drugs to 11 major Chinese cities, as a government pilot program designed to glean lower drug prices goes into effect. The two firms, AstraZeneca and Bristol-Myers Squibb, will supply key drugs at... Read More
China’s National Medical Products Administration (NMPA) in December began publicly soliciting opinions on proposed revisions to 94 medical device industry standards. The revisions, part of a broad reworking of medical device industry standards in China over the past two years, are expected... Read More
Addressing the rapid development of in-vitro diagnostics technologies and their increasing usefulness, China’s National Medical Products Administration (NMPA) in November refined its system of classifying in-vitro diagnostic (IVD) devices to better reflect the varying levels of risk they contain. Under the new... Read More
This article was originally published on MedTech Intelligence. How are Augmented and Virtual Reality Technologies Used in Healthcare? Augmented reality (AR) superimposes computer-generated images, sounds, or other sensory experiences on a user’s view of the real world. Virtual reality (VR) takes the... Read More
Drugs needed to treat emergency room patients are often in short supply or unavailable in Chinese hospitals, according to a joint study by researchers in Australia and China released October 9. The drug shortage is serious and is having significant effects on... Read More
Seeking to stem widespread tobacco dependency in a country that is the largest producer and consumer in the world, Chinese cities are increasingly implementing strict new restrictions on smoking in public. This November, Xi’an, the capital of Shaanxi province in northwest China... Read More
Growth and interest in biotechnology is growing in key Asian markets, driven by increased government spending, a loosening of regulations, price reforms and private sector funding. China leads Asia in biotech research and development, number of companies, jobs and IPOs. The government... Read More
Moving to implement a program to speed the review and approval of dozens of drugs sold abroad but not yet approved in China, the China Food and Drug Administration (CFDA) has established special channels to approve clinically urgently listed new drugs. The... Read More
With rates of hepatitis B infection higher in Asia than anywhere else on the globe, deaths from liver cancer are an overwhelmingly Asian phenomenon. Almost 80 percent of cases and deaths from liver cancer occur on the Asian continent, according to the... Read More